92 associate research director jobs at 47 companies in Fairfax, CA
3mo
Save
Mark Applied
Hide
3mo
Associate Director of Research & Assessment
San Francisco, California, United States
$76k-$92k/yrOnsiteFull Time
University of San Francisco: Jesuit nonprofit university serving undergraduate and graduate students in San Francis.
5+ YOEMaster’s degree in a related field; 5 years of higher education assessment experience; strong research methods; proficiency with Tableau and Qualtrics; excellent communication and organization.
Associate Director, Health Economics & Outcomes Research (HEOR)
San Rafael, California, United States
OnsiteFull Time
BioMarin PharmaceuticalNasdaq: BMRN: Develops therapies for rare genetic diseases.
7+ YOERequires 7+ years of pharmaceutical industry experience, including 4+ years in HEOR and 2+ years in patient-relevant outcomes research, plus an advanced degree and HTA and market access expertise.
Associate Director, Health Economics & Outcomes Research (HEOR)
San Rafael, California, United States
$153k-$210k/yrHybridFull Time
BioMarin PharmaceuticalNasdaq: BMRN: Develops therapies for rare genetic diseases.
7+ YOERequires 7+ years of pharmaceutical industry experience, including 4+ years in HEOR and 2+ years in patient-relevant outcomes research, plus an advanced degree and expertise in payer, market access, and HTA frameworks.
Joint Clinical Assessment (JCA), NICE, CADTH, time trade-off, standard gamble
Cartography Biosciences: Private oncology biotechnology developing antibody-based therapies designed to target tumors more precisely for patients with cancer.
6+ YOEPhD (or MS with commensurate experience) with 6+ years (Associate Director) or 9+ years (Director) industry experience; CDMO management, mammalian expression, antibody purification, analytical methods, and developability expertise.
Associate Director, Research Strategic Planning and Operation-Project Management
San Francisco, California, United States
$163k-$228k/yrHybridFull Time
Vir BiotechnologyNasdaq Global Select Market: VIR: Clinical-stage biopharmaceutical developing immune-system therapies for serious infectious diseases and cancer.
12+ YOE12+ years drug development experience, Bachelor's in a scientific discipline required; project management expertise; strong scientific acumen, communication, and cross-functional leadership; proficient with MS Office and SmartSheet.
Denali TherapeuticsNASDAQ: DNLI: Developing barrier-crossing medicines for people with neurodegenerative, lysosomal storage, and other serious diseases
SLAC National Accelerator Laboratory: Department of Energy national laboratory operated by Stanford University, conducting multidisciplinary research and providing X-ray facilities worldwide.
10+ YOEPh.D. in relevant science or engineering; distinguished synchrotron or accelerator-science research record; 10+ years relevant experience; complex R&D leadership, funding, strategy, and team-management expertise.
AbbVieNYSE: ABBV: Global biopharmaceutical discovering and delivering innovative medicines.
6+ YOEBachelor's degree and 6+ years' experience, or master's with 4+ years, or doctorate with 2+ years. Requires biopharma expertise, consulting or pharmaceutical experience, strategic problem-solving, communication, project leadership, and change management.
Latigo BiotherapeuticsNasdaq Global Select Market: LTGO: Clinical-stage biopharmaceutical developing non-opioid pain medicines for rapid pain relief without addiction risk.
10+ YOEPhD-level toxicology expertise with ~10+ years industry experience in nonclinical safety, IND-enabling studies, CRO oversight, regulatory strategy, and strong scientific judgment and communication.
2+ YOEBachelor's plus 10 years, master's plus 8 years, or PhD plus 2 years; statistical leadership, clinical trial expertise, regulatory communication, team leadership, and direct supervision experience required.
SepternaNasdaq Global Market: SEPN: Clinical-stage biotechnology discovering oral small-molecule medicines targeting GPCRs for patients with endocrine, inflammatory, and metabolic diseases.
7+ YOEPhD, MS, or BS in organic chemistry or related field with 7, 10, or 12 years of industry experience; expertise in process development, scale-up, manufacturing, quality systems, regulatory documentation, and CDMO management.
Olema OncologyNasdaq: OLMA: Clinical-stage biopharmaceutical developing targeted therapies for patients with metastatic breast cancer and other solid tumors.
8+ YOE8+ years FDA-regulated GMP/GMP QA experience with small-molecule drug substances, strong cGMP knowledge, experience with NDA/BLA submissions, CMO oversight, and Quality Management Systems.
Veeva, TrackWise, Microsoft Word, Microsoft Excel, Microsoft PowerPoint, Microsoft SharePoint
VaxcyteNasdaq: PCVX: Clinical-stage vaccine developing broad-spectrum vaccines against bacterial infections for children and adults worldwide.
7+ YOEPhD +7 years or MS +10 years in biopharmaceutical industry; deep hands-on immunoassay development, optimization, transfer, validation, and lifecycle support experience for vaccines/biologics; leadership and cross-functional collaboration skills.
Summit TherapeuticsNasdaq: SMMT: Public biopharmaceutical oncology developing investigational medicines for patients with serious unmet medical needs.
5+ YOEBA/BS required; advanced degree preferred. Requires 5+ years in scientific publications, medical affairs, or clinical development in pharma/biotech, with publication, vendor, and budget management experience.
ExelixisNASDAQ: EXEL: Public oncology biotechnology developing and commercializing small-molecule and biotherapeutic cancer medicines for patients.
11+ YOE2+ MgmtBS/BA with 11+ yrs or MS with 9+ yrs or PhD with 5+ yrs in related field; GMP and pharmaceutical industry experience; strong leadership, analytical, and regulatory skills.
Structure TherapeuticsNasdaq Global Market: GPCR: Public clinical-stage biopharmaceutical developing oral small-molecule medicines for patients with chronic diseases including obesity.
8+ YOE6+ Mgmt8+ years clinical operations experience in pharma/biotech/CRO, 6+ years in CRA/CTM roles, bachelor's degree required (advanced degree preferred), strong GCP/regulatory knowledge, global trial and vendor leadership experience.
Dompé: Italian family-owned biopharmaceutical developing, manufacturing, and commercializing medicines for patients with high unmet needs.
3+ YOEAdvanced scientific or clinical degree or equivalent experience; 3-5+ years in medical affairs, field medical, or stakeholder engagement; HCP/KOL compliance knowledge and strong project, organizational, and communication skills.
Corcept TherapeuticsNasdaq Capital Market: CORT: Public biopharmaceutical developing and commercializing cortisol-modulating medicines for severe endocrine, cancer, metabolic, and neurologic disorders.
2+ YOEMD, board-certified or eligible, preferably in oncology; 2+ years of clinical development experience in biotechnology, pharmaceutical, or academic trial settings; strong clinical research and communication skills.
Associate Director, Biostatistics Clinical Late Stage
Redwood City, California, United States
$186k-$233k/yrHybridFull Time
Revolution MedicinesNASDAQ: RVMD: Clinical-stage oncology developing targeted RAS-addicted cancer therapies.
5+ YOEPh.D. (5+ yrs) or M.S. (8+ yrs) in Statistics/Biostatistics; hands-on late-stage oncology trial design and analysis; proficiency in SAS and/or R; knowledge of ICH/regulatory requirements; strong communication and project management.
Associate Director - Computational Biology (Cardiovascular, Metabolic, Obesity and Related)
South San Francisco or Cambridge or Thousand Oaks
$190k-$257k/yrHybridFull Time
AmgenNASDAQ: AMGN: Developing innovative medicines to fight serious diseases.
4+ YOEPhD with 4+ yrs or MS with 7+ yrs or BS with 9+ yrs in computational biology/biomedical data; strong R/Python; cardiovascular/metabolic focus; matrixed environment experience.